Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Nausea × Clear all

Phase

Phase NA 9 Phase 3 9 Phase 2 9 Phase 2/3 3 Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 30 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Pain 14 Polycystic Ovary Syndrome 13 Leukemia 12 Keratosis, Actinic 10 Carcinoma, Hepatocellular 10 Uterine Cervical Neoplasms 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Leiomyoma 9 Colorectal Neoplasms 9 Carcinoma, Renal Cell 9 Brain Neoplasms 8 Neoplasm Metastasis 7 Melanoma 7 Lymphoma, Follicular 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Neuroendocrine Tumors 6 Lymphoma 6 Liver Neoplasms 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Head and Neck Neoplasms 6 Arthritis, Rheumatoid 6 Papillomavirus Infections 5 Multiple Myeloma 5 Leukemia, Myeloid, Acute 5

Interventions

dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 alizapride 1 Tropisetron 1 Ondansetron 1 Metoclopramide 1 Granisetron 1 Dexamethasone 1 Calcium Dobesilate 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡